Cargando…

The First Sign of Recurrent Angioimmunoblastic T-Cell Lymphoma: A Cutaneous Presentation

Angioimmunoblastic T-cell lymphoma (AITL) is a subtype of peripheral T-cell lymphoma with a nonspecific clinical presentation. Cutaneous manifestations of AITL are variable and include morbilliform eruptions, urticaria, papulonodules, and erythroderma. We present the case of a 74-year-old male with...

Descripción completa

Detalles Bibliográficos
Autores principales: Charest, Guy, McBride, Michael, Thomas, Amanda K, Manway, Mitch, DiCaudo, David J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558893/
https://www.ncbi.nlm.nih.gov/pubmed/37809113
http://dx.doi.org/10.7759/cureus.44805
_version_ 1785117383621345280
author Charest, Guy
McBride, Michael
Thomas, Amanda K
Manway, Mitch
DiCaudo, David J
author_facet Charest, Guy
McBride, Michael
Thomas, Amanda K
Manway, Mitch
DiCaudo, David J
author_sort Charest, Guy
collection PubMed
description Angioimmunoblastic T-cell lymphoma (AITL) is a subtype of peripheral T-cell lymphoma with a nonspecific clinical presentation. Cutaneous manifestations of AITL are variable and include morbilliform eruptions, urticaria, papulonodules, and erythroderma. We present the case of a 74-year-old male with a medical history of AITL presenting with diffuse erythematous macules and papules coalescing into patches and plaques on the trunk and bilateral upper extremities. Histopathology demonstrated a mild perivascular lymphocytic infiltrate in the dermis. By immunohistochemistry, the lymphocytic infiltrate was strongly positive for programmed cell death protein 1 (PD-1) (CD279) as well as cluster of differentiation 3 (CD3), CD5, and (focally) B-cell lymphoma-6 (BCL-6). Many cells within the infiltrate were positive for Epstein-Barr virus (EBV) by in situ hybridization. Additionally, a bone marrow biopsy demonstrated an atypical lymphoid infiltrate with T-cell predominance, many EBV-positive cells, and clonal T-cell receptor (TCR) beta gene rearrangement. Based on these histopathological findings, a diagnosis of recurrent AITL with cutaneous involvement was made. This case is a rare example of skin findings presenting as a first sign of recurrent AITL.
format Online
Article
Text
id pubmed-10558893
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-105588932023-10-08 The First Sign of Recurrent Angioimmunoblastic T-Cell Lymphoma: A Cutaneous Presentation Charest, Guy McBride, Michael Thomas, Amanda K Manway, Mitch DiCaudo, David J Cureus Dermatology Angioimmunoblastic T-cell lymphoma (AITL) is a subtype of peripheral T-cell lymphoma with a nonspecific clinical presentation. Cutaneous manifestations of AITL are variable and include morbilliform eruptions, urticaria, papulonodules, and erythroderma. We present the case of a 74-year-old male with a medical history of AITL presenting with diffuse erythematous macules and papules coalescing into patches and plaques on the trunk and bilateral upper extremities. Histopathology demonstrated a mild perivascular lymphocytic infiltrate in the dermis. By immunohistochemistry, the lymphocytic infiltrate was strongly positive for programmed cell death protein 1 (PD-1) (CD279) as well as cluster of differentiation 3 (CD3), CD5, and (focally) B-cell lymphoma-6 (BCL-6). Many cells within the infiltrate were positive for Epstein-Barr virus (EBV) by in situ hybridization. Additionally, a bone marrow biopsy demonstrated an atypical lymphoid infiltrate with T-cell predominance, many EBV-positive cells, and clonal T-cell receptor (TCR) beta gene rearrangement. Based on these histopathological findings, a diagnosis of recurrent AITL with cutaneous involvement was made. This case is a rare example of skin findings presenting as a first sign of recurrent AITL. Cureus 2023-09-06 /pmc/articles/PMC10558893/ /pubmed/37809113 http://dx.doi.org/10.7759/cureus.44805 Text en Copyright © 2023, Charest et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Charest, Guy
McBride, Michael
Thomas, Amanda K
Manway, Mitch
DiCaudo, David J
The First Sign of Recurrent Angioimmunoblastic T-Cell Lymphoma: A Cutaneous Presentation
title The First Sign of Recurrent Angioimmunoblastic T-Cell Lymphoma: A Cutaneous Presentation
title_full The First Sign of Recurrent Angioimmunoblastic T-Cell Lymphoma: A Cutaneous Presentation
title_fullStr The First Sign of Recurrent Angioimmunoblastic T-Cell Lymphoma: A Cutaneous Presentation
title_full_unstemmed The First Sign of Recurrent Angioimmunoblastic T-Cell Lymphoma: A Cutaneous Presentation
title_short The First Sign of Recurrent Angioimmunoblastic T-Cell Lymphoma: A Cutaneous Presentation
title_sort first sign of recurrent angioimmunoblastic t-cell lymphoma: a cutaneous presentation
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558893/
https://www.ncbi.nlm.nih.gov/pubmed/37809113
http://dx.doi.org/10.7759/cureus.44805
work_keys_str_mv AT charestguy thefirstsignofrecurrentangioimmunoblastictcelllymphomaacutaneouspresentation
AT mcbridemichael thefirstsignofrecurrentangioimmunoblastictcelllymphomaacutaneouspresentation
AT thomasamandak thefirstsignofrecurrentangioimmunoblastictcelllymphomaacutaneouspresentation
AT manwaymitch thefirstsignofrecurrentangioimmunoblastictcelllymphomaacutaneouspresentation
AT dicaudodavidj thefirstsignofrecurrentangioimmunoblastictcelllymphomaacutaneouspresentation
AT charestguy firstsignofrecurrentangioimmunoblastictcelllymphomaacutaneouspresentation
AT mcbridemichael firstsignofrecurrentangioimmunoblastictcelllymphomaacutaneouspresentation
AT thomasamandak firstsignofrecurrentangioimmunoblastictcelllymphomaacutaneouspresentation
AT manwaymitch firstsignofrecurrentangioimmunoblastictcelllymphomaacutaneouspresentation
AT dicaudodavidj firstsignofrecurrentangioimmunoblastictcelllymphomaacutaneouspresentation